Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable

N Yang1, J-P Feng, G Chen

  • 1Department of Cardiology, and Department of Cardiology Medicine, Tianjin Chest Hospital, Tianjin, China. qinqin6999@163.com.

Insights

Physicians hesitate to use lipid-lowering therapy in acute myocardial infarction (AMI) patients with low lipid levels. However, lower lipid levels in AMI are linked to inflammation, not a contraindication for therapy.

Area of Science:

  • Cardiology
  • Biochemistry
  • Internal Medicine

Background:

  • Coronary artery disease (CAD) management guidelines emphasize lipid-lowering therapy.
  • Physicians express concern regarding initiating lipid-lowering therapy in acute myocardial infarction (AMI) patients presenting with low serum lipid levels.
  • The adequacy of lipid-lowering therapy in AMI patients with low lipid profiles requires further exploration.

Purpose of the Study:

  • To investigate the adequacy of lipid-lowering therapy in patients experiencing acute myocardial infarction (AMI).
  • To analyze lipid profiles and clinical characteristics in different coronary artery disease (CAD) patient groups.

Main Methods:

  • Collected lipid profile data from over 3000 coronary artery disease (CAD) patients.
  • Categorized patients into three groups: acute myocardial infarction (AMI), stable angina pectoris (SAP), and unstable angina pectoris (UAP).
  • Performed statistical analyses to compare baseline lipid levels and clinical features across the groups.

Main Results:

  • Patients with AMI exhibited the lowest levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c) compared to UAP and SAP groups.
  • Significant differences were observed in white blood count (WBC) and ejection fraction (EF) among the three groups.
  • A strong correlation was found between ejection fraction (EF%) and lipid parameters (TC, LDL-c, HDL-c, non-HDL-c); WBC correlated with HDL-c only.

Conclusions:

  • Lower lipid levels (TC, LDL-c, HDL-c) in AMI patients are associated with the acute inflammatory response during atherosclerotic plaque rupture.
  • The acute inflammatory reaction in AMI influences lipid levels.
  • Lipid-lowering therapy should be initiated promptly in AMI patients, irrespective of their baseline lower lipid levels.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
459
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
671
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
805
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
483
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
446
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K